Ipca Laboratories Limited (NSE: IPCALAB)

Ipca Laboratories Revenue

Ipca Laboratories had revenue of 23.55B INR in the quarter ending September 30, 2024, with 15.78% growth. This brings the company's revenue in the last twelve months to 85.34B, up 27.75% year-over-year. In the fiscal year ending March 31, 2024, Ipca Laboratories had annual revenue of 77.06B with 23.33% growth.

• Revenue (ttm): 85.34B
• Revenue Growth: +27.75%
• P/S Ratio: 4.71
• Revenue / Employee: 4.92M
• Employees: 17,335
• Market Cap: 401.49B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	77.06B	14.58B	23.33%
Mar 31, 2023	62.48B	4.18B	7.16%
Mar 31, 2022	58.31B	4.10B	7.56%
Mar 31, 2021	54.21B	7.71B	16.58%
Mar 31, 2020	46.50B	8.75B	23.18%